KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-192.32M
↓ 128% vs avg
Percentile
P0
Near historical low
Streak
8 yr
Consecutive declineContracting
Average
$-84.27M
Historical baseline
PeriodValueYoY Change
TTM$-192.32M-11.0%
2025$-173.33M-29.1%
2024$-134.28M-42.3%
2023$-94.37M-16.9%
2022$-80.75M-40.7%
2021$-57.39M-43.4%
2020$-40.02M-35.9%
2019$-29.44M-58.9%
2018$-18.52M+16.9%
2017$-22.30M-